Axsome Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of AXSM for the last quarter is 71.53 M USD, and it's 23.77% higher compared to the previous quarter. The net income of Q4 23 is -98.65 M USD.